Published in Hepatology · View the paper (DOI)
A global prevalence study reveals that HCV genotype 1 accounts for over 46% of all cases, followed by genotypes 3 and 2. The study emphasizes the importance of understanding viral genotype to develop new treatments for HCV.
Coverage from 2 institutions